Dr Adcock is board certified in anatomic and clinical pathology. She earned her medical degree at Michigan State University and completed residency training in pathology at the University of Colorado.
Dr Adcock has worked as an anatomical and clinical pathologist and has spent the last 25 years focused on hemostasis testing. Her area of expertise is laboratory hemostasis with an emphasis on quality in laboratory medicine, pre-examination variables, clinical consultation, teaching, and standard setting.
Dr Adcock is a current chair of the FDA Hematology and Pathology Devices Panel. She is an appointed member of the American Board of Pathology Test Development and Advisory Committee and vice president of the North American Specialized Coagulation Laboratory Association. She serves on the College of American Pathologists (CAP) Phlebotomy Committee and is a previous member of the CAP Coagulation Resource Council. She chaired the CLSI committees on H21 (collection, transport, and processing of blood specimens for testing plasma-based coagulation assays) and H54 (procedures of validation of INR and local calibration of PT/INR systems). Dr Adcock is also a member of the American Society for Clinical Pathology and past president of the American Thrombosis Association.
Dr Adcock has authored more than 120 peer-reviewed publications, multiple book chapters, and numerous coagulation-based laboratory guidelines.